The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Patrick Garnero

INSERM Research Unit 664

France

[email]@synarc.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • INSERM Research Unit 664, France. 2001 - 2009
  • INSERM Unit 664, Synarc Lyon, 16 rue Montbrillant, France. 2007 - 2009
  • INSERM Unit 664, Laënnec School of Medicine, France. 2008
  • Molecular Markers, Synarc, France. 2005 - 2006
  • Synarc, Molecular Markers, Le Buroparc Batîment T4, 16 rue Montbrillant, France. 2006
  • INSERM Research Unit 403, Hôpital E Herriot, Pavillon F, 69437 Lyon Cedex 03, France. 2001 - 2006
  • INSERM and Synarc Molecular Markers, Molecular Marker Division, France. 2006
  • Synarc, France. 2005
  • INSERM U-403, Hôpital E. Herriot, France. 1999 - 2003
  • University Hospital Maastricht, Maastricht, Netherlands. 2003

References

  1. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations. Garnero, P., Schott, A.M., Prockop, D., Chevrel, G. Bone (2009) [Pubmed]
  2. Bone markers in osteoporosis. Garnero, P. Curr. Osteoporos. Rep (2009) [Pubmed]
  3. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring. Garnero, P. Mol. Diagn. Ther (2008) [Pubmed]
  4. Circulating dickkopf-1 and radiological progression in patients with early rheumatoid arthritis treated with etanercept. Garnero, P., Tabassi, N.C., Voorzanger-Rousselot, N. J. Rheumatol. (2008) [Pubmed]
  5. Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial. Garnero, P., Aronstein, W.S., Cohen, S.B., Conaghan, P.G., Cline, G.A., Christiansen, C., Beary, J.F., Meyer, J.M., Bingham, C.O. Osteoarthr. Cartil. (2008) [Pubmed]
  6. Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis. Garnero, P., Vergnaud, P., Hoyle, N. Clin. Chem. (2008) [Pubmed]
  7. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Garnero, P., Munoz, F., Sornay-Rendu, E., Delmas, P.D. Bone (2007) [Pubmed]
  8. Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis. Garnero, P., Charni, N., Juillet, F., Conrozier, T., Vignon, E. Ann. Rheum. Dis. (2006) [Pubmed]
  9. Use of biochemical markers to study and follow patients with osteoarthritis. Garnero, P. Curr. Rheumatol. Rep (2006) [Pubmed]
  10. Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Garnero, P., Borel, O., Gineyts, E., Duboeuf, F., Solberg, H., Bouxsein, M.L., Christiansen, C., Delmas, P.D. Bone (2006) [Pubmed]
  11. Biochemical markers in osteoarthritis: will they measure up?. Garnero, P. Nature Clinical Practice. Rheumatology (2006) [Pubmed]
  12. Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. Garnero, P., Mazières, B., Guéguen, A., Abbal, M., Berdah, L., Lequesne, M., Nguyen, M., Salles, J.P., Vignon, E., Dougados, M. J. Rheumatol. (2005) [Pubmed]
  13. Vitamin D receptor gene polymorphisms are associated with the risk of fractures in postmenopausal women, independently of bone mineral density. Garnero, P., Munoz, F., Borel, O., Sornay-Rendu, E., Delmas, P.D. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  14. Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study. Garnero, P., Peterfy, C., Zaim, S., Schoenharting, M. Arthritis Rheum. (2005) [Pubmed]
  15. Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkers. Garnero, P., Delmas, P.D. Curr. Opin. Rheumatol (2004) [Pubmed]
  16. Association between spine disc degeneration and type II collagen degradation in postmenopausal women: the OFELY study. Garnero, P., Sornay-Rendu, E., Arlot, M., Christiansen, C., Delmas, P.D. Arthritis Rheum. (2004) [Pubmed]
  17. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women. Garnero, P., Delmas, P.D. J. Musculoskelet. Neuronal. Interact (2004) [Pubmed]
  18. An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis. Garnero, P., Delmas, P.D. Bone (2003) [Pubmed]
  19. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. Garnero, P., Ferreras, M., Karsdal, M.A., Nicamhlaoibh, R., Risteli, J., Borel, O., Qvist, P., Delmas, P.D., Foged, N.T., Delaissé, J.M. J. Bone Miner. Res. (2003) [Pubmed]
  20. Biomarkers in osteoarthritis. Garnero, P., Delmas, P.D. Curr. Opin. Rheumatol (2003) [Pubmed]
  21. Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Garnero, P., Conrozier, T., Christgau, S., Mathieu, P., Delmas, P.D., Vignon, E. Ann. Rheum. Dis. (2003) [Pubmed]
  22. Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study. Garnero, P., Mulleman, D., Munoz, F., Sornay-Rendu, E., Delmas, P.D. J. Bone Miner. Res. (2003) [Pubmed]
  23. Biochemical markers of joint tissue turnover in early rheumatoid arthritis. Garnero, P., Geusens, P., Landewé, R. Clin. Exp. Rheumatol. (2003) [Pubmed]
  24. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. Garnero, P., Gineyts, E., Christgau, S., Finck, B., Delmas, P.D. Arthritis Rheum. (2002) [Pubmed]
  25. Association between a functional interleukin-6 gene polymorphism and peak bone mineral density and postmenopausal bone loss in women: the OFELY study. Garnero, P., Borel, O., Sornay-Rendu, E., Duboeuf, F., Jeffery, R., Woo, P., Delmas, P.D. Bone (2002) [Pubmed]
  26. Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial. Garnero, P., Jamin, C., Benhamou, C.L., Pelissier, C., Roux, C. Hum. Reprod. (2002) [Pubmed]
  27. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Garnero, P., Ayral, X., Rousseau, J.C., Christgau, S., Sandell, L.J., Dougados, M., Delmas, P.D. Arthritis Rheum. (2002) [Pubmed]
  28. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Garnero, P., Landewé, R., Boers, M., Verhoeven, A., Van Der Linden, S., Christgau, S., Van Der Heijde, D., Boonen, A., Geusens, P. Arthritis Rheum. (2002) [Pubmed]
  29. Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. Garnero, P., Borel, O., Delmas, P.D. Clin. Chem. (2001) [Pubmed]
  30. The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone. Garnero, P., Christgau, S., Delmas, P.D. Bone (2001) [Pubmed]
  31. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Garnero, P., Piperno, M., Gineyts, E., Christgau, S., Delmas, P.D., Vignon, E. Ann. Rheum. Dis. (2001) [Pubmed]
  32. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women. Garnero, P., Tsouderos, Y., Marton, I., Pelissier, C., Varin, C., Delmas, P.D. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
 
WikiGenes - Universities